Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma
肺腺癌中,药物耐受性和对EGFR抑制剂治疗的持续性是由ILK-SFK-YAP信号通路介导的。
期刊:Oncogene
影响因子:7.3
doi:10.1038/s41388-025-03461-6
Shi, Rocky; Farnsworth, Dylan A; Febres-Aldana, Christopher A; Chow, Justine L M; Sheena, Ravinder; Atwal, Tejveer; Gomez Marti, Juan Luis; Li, Samantha; Thomas, Kiersten N; Lee, Che-Min; Awrey, Shannon J; McDonald, Paul C; Somwar, Romel; Dedhar, Shoukat; Ladanyi, Marc; Bennewith, Kevin L; Lockwood, William W